0      0

2023 Aseptic Conference

SES106b - Evolution of Viral Vector Therapies – A Facilities Perspective

‐ Mar 6, 2023 3:00pm

Viral Vectors (VV) based ATMP Therapies have been in commercial manufacturing for over 10 years. The science of VV-based ATMPs continues to evolve rapidly. This has had a marked impact to the design of ATMP manufacturing facilities. This presentation reviews three case studies which demonstrate the evolution of facilities designed and built in the past 5 years. The presentation will showcase how facility design innovation has evolved as the therapies and their manufacturing has become more complicated.


You must be logged in and own this session in order to post comments.